Skip to main content

Advertisement

Table 2 Clinical signs of patients at inclusion

From: Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa

  DP (n, %) AL (n, %) Total n (%)
Fever 197 (100%) 187 (100%) 384 (100)
Headache 167 (84.8%) 153 (81.8%) 320 (83.3)
Asthenia 153 (81.8%) 106 (56.7%) 223 (58.1)
Anorexia 103 (52.3%) 95 (50.8%) 198 (51.6)
Shiver 93 (47.2%) 80 (42.8%) 173 (45.1)
Joint pain 77 (39.1%) 75 (40.1%) 152 (39.6)
Abdominal pain 35 (17.8%) 43 (23%) 78 (20.3)
Insomnia 18 (9.1%) 23 (12.3%) 41 (10.7)
Dizziness 18 (9.1%) 13 (6.9%) 31 (8.1)